We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DORM:NASDAQDorman Products, Inc. Analysis

Data as of 2026-03-29 - not real-time

$104.56

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Dorman Products is trading around $104.56, hugging the lower end of its 30‑day range and sitting just above the identified support level of $98.45. The stock is below its 20‑day ($106.6), 50‑day ($118.4) and 200‑day ($132.4) simple moving averages, confirming a bearish trend, while the RSI at 36 indicates the price may be approaching oversold conditions. A bullish MACD histogram (+0.85) and a MACD line that has crossed above the signal line suggest short‑term momentum could be turning positive despite the broader downtrend. Volatility remains elevated at roughly 36% over the past month, but the beta of 0.65 points to relatively modest market‑wide sensitivity. The latest earnings release showed Q4 sales of $537.9 million and a modest net income increase, yet a $56.7 million goodwill impairment in the Heavy Duty segment weighed on results. Management highlighted record new‑product activity and a strategic reduction in China sourcing, while guiding 2026 net sales growth of 7‑9%, which fell short of market expectations and nudged the share price lower. Fundamentally, the company trades at a forward P/E of about 11.3 versus a trailing P/E of 15.7, and its price‑to‑book of 2.15 is well below the sector average, implying valuation headroom. Analyst consensus remains strongly bullish, with a median target of $152.5, representing roughly a 46% upside from current levels.
Given the combination of a solid balance sheet, modest debt load, and no dividend obligations, Dorman offers an attractive entry point for investors seeking exposure to the auto‑parts aftermarket. The upside potential is tempered by high short‑term volatility and a weaker-than‑expected outlook, but the long‑term growth narrative—driven by new product launches and supply‑chain diversification—supports a favorable risk‑adjusted case. Investors should weigh the near‑term price weakness against the sizable upside implied by analyst targets and the company’s resilient earnings profile.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price near support with bearish moving averages
  • Oversold RSI suggesting limited downside
  • Recent earnings beat but weak guidance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Forward P/E compression to ~11x
  • Analyst median target indicating ~46% upside
  • Strategic reduction of China exposure and new product pipeline

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable earnings margins and cash flow generation
  • Low debt‑to‑equity profile and strong ROE
  • Secular demand for aftermarket automotive parts

Key Metrics & Analysis

Financial Health

Revenue Growth0.80%
Profit Margin9.59%
P/E Ratio15.7
ROE14.74%
ROA9.06%
Debt/Equity37.98
P/B Ratio2.2
Op. Cash Flow$113.6M
Free Cash Flow$11.6M

Technical Analysis

TrendBearish
RSI36.6
Support$98.45
Resistance$121.21
MA 20$106.62
MA 50$118.45
MA 200$132.45
MACDBullish
VolumeStable
Fear & Greed Index65.98

Valuation

Target Price$153.38
Upside/Downside46.69%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.65
Volatility36.06%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.